In addition to hormone metabolism, CYP3A4 is also involved in the metabolism of approximately half of all marketed drugs, therefore individuals with differences in CYP3A4 expression might have different responses to any number of exogenous compounds, including oral contraceptives, an ovarian cancer protective factor. This evidence concerns the gene CYP3A4 and ovarian cancer.